Mitochondrial dysfunction and liver disease: role, relevance, and potential for therapeutic modulation
Paul Middleton1, Nikhil Vergis2
1Department of Metabolism, Digestion and Reproduction, Imperial College London, St Mary's Hospital, Praed Street, London, SW7 2AZ, UK.
Therapeutic Advances in Gastroenterology
|August 11, 2021
Summary
Mitochondrial dysfunction is implicated in chronic liver diseases and cancer. Therapies targeting mitochondria show promise for treating these conditions.
Area of Science:
- Cell Biology
- Metabolic Diseases
- Hepatology
Background:
- Mitochondria are vital for cellular energy and metabolism.
- Mitochondrial dysfunction is increasingly linked to chronic diseases and cancer.
- Liver diseases share common mitochondrial defects despite differing causes.
Purpose of the Study:
- To review the role of mitochondria in liver disease pathophysiology.
- To explore common mitochondrial defects in various liver conditions.
- To examine the potential of mitochondrial-targeted therapies.
Main Methods:
- Literature review of studies on mitochondria in liver disease.
- Analysis of patient tissue and disease models.
- Synthesis of findings on mitochondrial dysfunction and therapeutic strategies.
Main Results:
- Mitochondrial dysfunction is prevalent in alcohol-related liver disease, non-alcoholic fatty liver disease, chronic hepatitis B, and hepatocellular carcinoma.
- Common defects include increased reactive oxygen species production and impaired oxidative phosphorylation.
- Mitochondrial-targeted therapies are emerging as potential treatments.
Conclusions:
- Mitochondrial dysfunction is a unifying factor in chronic liver diseases.
- Targeting mitochondria offers a promising therapeutic approach for liver disease management.
- Further research into mitochondrial-targeted therapies is warranted.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
37
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
37
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
36
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
36
01:46Electron Transport Chain: Complex I and II
15.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.5K
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
31
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
31
01:45Mitochondrial Membranes
13.3K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
13.3K
01:24Overview of Lipid Metabolism
3.2K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
3.2K